| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C0019068> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C0024291> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C0272199> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C3854325> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C3887558> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C4551514> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32584762_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'hans.hasselbalch@gmail.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Hasselbalch_Hans_Carl> <https://research.tib.eu/covid-19/entity/Kj%C3%A6r_Lasse> <https://research.tib.eu/covid-19/entity/Nielsen_Claus_Henrik> <https://research.tib.eu/covid-19/entity/Poulsen_Anne> <https://research.tib.eu/covid-19/entity/Poulsen_Troesl_Dirch> <https://research.tib.eu/covid-19/entity/Skov_Vibe>
?:doi	V04200234
?:doi	<https://research.tib.eu/covid-19/entity/V04200234>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Ugeskrift for laeger
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32584762>
?:pmid	<https://research.tib.eu/covid-19/entity/32584762>
?:pmid	32584762
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.115
?:rankingScore_hIndex	26
?:title	[Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia].
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32584762>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32584762>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all